Pathogenesis and Therapy of Sideroblastic Anemia
Pathogenesis and Therapy of Sideroblastic Anemia
批准号:
6761972
负责人:
JEFFREY S FRIEDMAN
金额:
$4.22万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-03-01 至 2003-06-30
中文摘要
描述(由申请人提供):铁粒幼细胞性贫血的发病机制和治疗:我们最近报道了一种新的由超氧化物歧化酶2(SOD 2)缺乏引起的Munne贫血,与人类铁粒幼细胞性贫血(SA)具有惊人的相似性。这种鼠模型系统提供了一个平台,从中进行研究,以更好地了解SA的病理生理学基础,以及有效治疗这种疾病的作用机制。SA是一组形态学上不同的疾病,其特征在于发育期间红细胞内过量铁的积累。最近已经阐明了几种SA亚型的遗传病变,并且在每种情况下都突出了线粒体作为血红素生物合成、铁转运或铁稳态在红细胞发育中的位点的重要性。SOD 2或锰SOD是一种关键的线粒体内催化抗氧化剂,这种酶的缺乏会导致小鼠胚胎或新生儿死亡。对Sod 2 - 1-幼仔的检查揭示了线粒体功能障碍的广泛证据,包括肌病、神经病和代谢紊乱。为了研究SOD 2缺乏的细胞自主效应,我们设计了一种移植系统,其中来自SOD 2缺失胚胎的造血干细胞(HSC)用于重建致死辐射宿主动物的免疫和造血组织,并发现由SOD 2缺失导致的主要表型是溶血性贫血。这一结果表明,继发于氧化应激增加的线粒体功能障碍,或者可能是红细胞发育过程中关键靶蛋白的直接氧化,可能是SA发病机制的核心。氧化损伤在SA模型中的重要性通过对一类新型抗氧化剂(催化SOD/过氧化氢酶模拟物)治疗的显著反应而进一步突出。该提案的主要重点是详细表征病理学、生物化学和基因表达谱,以确定受SOD 2缺失影响的关键分子靶标。第二个重点是记录催化抗氧化剂治疗如何影响这一“发病概况。“该提案的最终重点是使用基因表达谱数据来编译一组序列(人类同源物),可用于筛选来自人类SA病例的RNA。这些研究旨在确定SA中改变的常见分子途径,并将提供重要信息,以告知未来抗氧化剂作为SA治疗的治疗潜力的临床决策。
英文摘要
DESCRIPTION (provided by applicant): Pathogenesis and Therapy of Sideroblastic Anemia: We have recently reported on a novel munne anemia caused by deficiency of superoxide dismutase 2 (SOD2), that bears striking similarity to human sideroblastic anemia (SA). This murine model system provides a platform from which to conduct studies to better understand both the pathophysiology underlying SA, and the mechanism of action of an effective therapeutic for this condition. SA is a morphologically distinct group of disorders characterized by accumulation of excess iron within red cells during development. Genetic lesions responsible for several subtypes of SA have been recently elucidated, and in each case highlight the importance of mitochondria as a locus for heme biosynthesis, iron transport or iron homeostasis in developing red blood cells. SOD2, or Manganese SOD, is a critical intra-mitochondrial catalytic antioxidant, and deficiency of this enzyme leads to late embryonic or neonatal lethality in mice. Examination of Sod2 -I- pups reveals widespread evidence of mitochondrial dysfunction including myopathy, neuropathy and metabolic derangement. In order to study cell-autonomous effects of SOD2 deficiency, we devised a transplantation system in which hematopoietic stem cells (HSC) from Sod2 null embryos were used to reconstitute the immune and hematopoietic tissues of lethally irradiated host animals, and found that a major phenotype resulting from loss of SOD2 is a hemolytic anemia. This result suggested that mitochondrial dysfunction secondary to increased oxidative stress, or perhaps direct oxidation of key target proteins during red cell development, may be central to the pathogenesis of SA. The importance of oxidative damage in this model of SA was further highlighted by the dramatic response to therapy with a novel class of antioxidants, catalytic SOD/catalase mimetics. A primary focus of this proposal is detailed characterization of pathology, biochemistry and gene expression profile in order to identify key molecular targets affected by loss of SOD2. A secondary focus is to document how catalytic antioxidant therapy affects this 'pathogenetic profile.' The final focus of this proposal is to use the gene expression profiling data to compile a set of sequences (human homologues) that can be used for screening against RNA from cases of human SA. These studies are designed to identify common molecular pathways that are altered in SA, and will provide crucial information to inform clinical decision making regarding the therapeutic potential of antioxidants as therapy for SA in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
-
批准号:7654467
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
-
批准号:7934640
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
-
批准号:7591099
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2008
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
-
批准号:7387295
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2008
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7407984
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7797541
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Reactive Oxygen Species in Anti-Viral Airway Host Defense
-
批准号:7497538
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
DIGE Package: Variable Mode Imager and Spot Picker
-
批准号:7214952
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7591119
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
LEPTIN TREATMENT FOR PREVENTION OF THE METABOLIC AND ENDOCRINE SEQUELAE
-
批准号:7206993
-
项目类别:
-
资助金额:$69.99万
-
财政年份:2005
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6789691
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6711204
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6839428
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:7008475
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Leptin Treatment for Prevention of Metabolic & Endocrine
-
批准号:7041485
-
项目类别:
-
资助金额:$76.1万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6612104
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:7175400
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:2386364
-
项目类别:
-
资助金额:$8.16万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:6388426
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:6043686
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
海外基金